Elevated asparagine metabolism is associated with an immunosuppressive tumor microenvironment, marked by increased Alanine/Serine/Cysteine Transporter 2 (ASCT2) and decreased Glutaminase 2 (GLS2) expression [168,169]. The gene discussed is SLC1A5; the disease is neoplasm.